These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 23688241)
1. The expression of cytoglobin as a prognostic factor in gliomas: a retrospective analysis of 88 patients. Xu HW; Huang YJ; Xie ZY; Lin L; Guo YC; Zhuang ZR; Lin XP; Zhou W; Li M; Huang HH; Wei XL; Man K; Zhang GJ BMC Cancer; 2013 May; 13():247. PubMed ID: 23688241 [TBL] [Abstract][Full Text] [Related]
2. Cytoglobin as a Prognostic Factor for Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis of 75 Patients. Kono H; Hosomura N; Amemiya H; Kawaida H; Furuya S; Akaike H; Kawaguchi Y; Sudo M; Ichikawa D Pancreas; 2021 Aug; 50(7):994-999. PubMed ID: 34629450 [TBL] [Abstract][Full Text] [Related]
3. Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas. Wang XB; Tian XY; Li Y; Li B; Li Z J Neurooncol; 2012 Jan; 106(1):43-51. PubMed ID: 21725855 [TBL] [Abstract][Full Text] [Related]
4. Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro. Guo YF; Wang XB; Tian XY; Li Y; Li B; Huang Q; Zhang M; Li Z World J Surg Oncol; 2012 Jun; 10():128. PubMed ID: 22741575 [TBL] [Abstract][Full Text] [Related]
5. The positive correlation between DJ-1 and β-catenin expression shows prognostic value for patients with glioma. Wang C; Fang M; Zhang M; Li W; Guan H; Sun Y; Xie S; Zhong X Neuropathology; 2013 Dec; 33(6):628-36. PubMed ID: 23714193 [TBL] [Abstract][Full Text] [Related]
6. Cytoglobin inhibits migration through PI3K/AKT/mTOR pathway in fibroblast cells. Demirci S; Doğan A; Apdik H; Tuysuz EC; Gulluoglu S; Bayrak OF; Şahin F Mol Cell Biochem; 2018 Jan; 437(1-2):133-142. PubMed ID: 28620820 [TBL] [Abstract][Full Text] [Related]
7. 3D-ASL perfusion correlates with VEGF expression and overall survival in glioma patients: Comparison of quantitative perfusion and pathology on accurate spatial location-matched basis. Pang H; Dang X; Ren Y; Zhuang D; Qiu T; Chen H; Zhang J; Ma N; Li G; Zhang J; Wu J; Feng X J Magn Reson Imaging; 2019 Jul; 50(1):209-220. PubMed ID: 30652410 [TBL] [Abstract][Full Text] [Related]
8. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas. Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768 [TBL] [Abstract][Full Text] [Related]
9. Clinical and Pathologic Features and Prognostic Factors for Recurrent Gliomas. Li J; Niu X; Gan Y; Yang Y; Wang T; Zhang H; Liu Y; Mao Q World Neurosurg; 2019 Aug; 128():e21-e30. PubMed ID: 30880199 [TBL] [Abstract][Full Text] [Related]
11. PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome. Mueller S; Phillips J; Onar-Thomas A; Romero E; Zheng S; Wiencke JK; McBride SM; Cowdrey C; Prados MD; Weiss WA; Berger MS; Gupta N; Haas-Kogan DA Neuro Oncol; 2012 Sep; 14(9):1146-52. PubMed ID: 22753230 [TBL] [Abstract][Full Text] [Related]
12. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway. Li Y; Ma X; Wang Y; Li G Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210 [TBL] [Abstract][Full Text] [Related]
13. Cytoglobin has bimodal: tumour suppressor and oncogene functions in lung cancer cell lines. Oleksiewicz U; Liloglou T; Tasopoulou KM; Daskoulidou N; Bryan J; Gosney JR; Field JK; Xinarianos G Hum Mol Genet; 2013 Aug; 22(16):3207-17. PubMed ID: 23591990 [TBL] [Abstract][Full Text] [Related]
14. Cytoglobin may be involved in the healing process of gastric mucosal injuries in the late phase without angiogenesis. Tanaka F; Tominaga K; Sasaki E; Sogawa M; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Fujiwara Y; Kawada N; Yoshizato K; Arakawa T Dig Dis Sci; 2013 May; 58(5):1198-206. PubMed ID: 23306842 [TBL] [Abstract][Full Text] [Related]
15. FGF2 as a potential prognostic biomarker for proneural glioma patients. Sooman L; Freyhult E; Jaiswal A; Navani S; Edqvist PH; Pontén F; Tchougounova E; Smits A; Elsir T; Gullbo J; Lennartsson J; Bergqvist M; Ekman S Acta Oncol; 2015 Mar; 54(3):385-94. PubMed ID: 25263081 [TBL] [Abstract][Full Text] [Related]
17. The miR-139-5p regulates proliferation of supratentorial paediatric low-grade gliomas by targeting the PI3K/AKT/mTORC1 signalling. Catanzaro G; Besharat ZM; Miele E; Chiacchiarini M; Po A; Carai A; Marras CE; Antonelli M; Badiali M; Raso A; Mascelli S; Schrimpf D; Stichel D; Tartaglia M; Capper D; von Deimling A; Giangaspero F; Mastronuzzi A; Locatelli F; Ferretti E Neuropathol Appl Neurobiol; 2018 Dec; 44(7):687-706. PubMed ID: 29478280 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical characterization of lymphangiogenesis-related biomarkers in primary and recurrent gliomas: A STROBE compliant article. Jiang J; Wang S; Chen Y; Wang C; Qu C; Liu Y Medicine (Baltimore); 2018 Sep; 97(39):e12458. PubMed ID: 30278527 [TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer. Starska K; Forma E; Lewy-Trenda I; Stasikowska-Kanicka O; Skóra M; Bryś M Cell Oncol (Dordr); 2018 Jun; 41(3):253-268. PubMed ID: 29299828 [TBL] [Abstract][Full Text] [Related]
20. Promotion of liver and lung tumorigenesis in DEN-treated cytoglobin-deficient mice. Thuy le TT; Morita T; Yoshida K; Wakasa K; Iizuka M; Ogawa T; Mori M; Sekiya Y; Momen S; Motoyama H; Ikeda K; Yoshizato K; Kawada N Am J Pathol; 2011 Aug; 179(2):1050-60. PubMed ID: 21684245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]